Risk analysis by FMEA as an element of analytical validation

JF van, LeeuwenNauta, MJde Kaste, DrivmYMCF, Odekerken-RomboutsMT, OldenhofVredenbregt, MJBarends, DMrivm2025-03-192025-03-1920091964066810.1016/j.jpba.2009.06.049https://rivm.openrepository.com/handle/10029/643963Risk analysis by FMEA as an element of analytical validationArticleJ Pharm Biomed Anal 2009; 50(5):1085-72025-03-19